Matrix Trust Company’s Pfizer PFE Stock Holding History

Matrix Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,518	Closed	-$511K	–	64
2023 Q1	$511K	Buy	12,518 +315	+3%	+$13.6K	0.14%	49
2022 Q4	$625K	Buy	12,203 +4,252	+53%	+$204K	0.16%	49
2022 Q3	$348K	Sell	7,951 -5,307	-40%	-$258K	0.1%	47
2022 Q2	$695K	Buy	13,258 +8,568	+183%	+$437K	0.19%	34
2022 Q1	$243K	Buy	+4,690	New	+$243K	0.06%	39

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Matrix Trust Company's PFE Position: Q2 2023 in Review

Matrix Trust Company sold out of Pfizer (PFE) in Q2 2023, closing a stake of 12,518 shares — an estimated $511K sold.

Matrix Trust Company first reported a position in PFE in Q1 2022 and held it in 5 quarters. The position peaked at $695K in Q2 2022. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

Matrix Trust Company reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
Matrix Trust Company sold 12,518 Pfizer shares in Q2 2023, an estimated $511K.
Matrix Trust Company first reported a position in Pfizer in Q1 2022 and held it in 5 quarters.
Matrix Trust Company's Pfizer position peaked at $695K in Q2 2022.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Matrix Trust Company's 13F filing for Q2 2023, filed 19 Jul 2023.